Editas Medicine (EDIT) Net Margin (2015 - 2025)
Editas Medicine's Net Margin was -332.98% in Q3 2025, up 101537.51 percentage points from -101870.49% a year earlier and up 1154.86 percentage points from the prior quarter.
Powered by 
Analysis
Editas Medicine (EDIT) Net Margin (2015 - 2025) Analysis & Trends
On a trailing twelve-month basis, Editas Medicine's Net Margin was -430.84% through Sep 30, 2025, down 89.87 percentage points year-over-year; for FY2024, it was -733.72%, down 537.59 percentage points from FY2023.
- Net Margin shows a five-year change of -82.28 percentage points (FY2019 to FY2024).
- In earlier years, Net Margin was -196.13% in FY2023 (+922.14 pp), -1118.26% in FY2022 (-364.65 pp), -753.61% in FY2021 (-625.79 pp) and -127.82% in FY2020 (+523.61 pp).
- Quarterly Net Margin has moved between -132680.95% (Q3 2022) and -31.43% (Q4 2023) over five years.
- Compared with a year earlier, Net Margin has increased for three straight quarters, with an average year-over-year change of +7.96 percentage points over the last eight quarters.
- The best year-over-year quarter for Net Margin over five years was Q3 2023 (a gain of 131837.27 percentage points); the worst was Q3 2022 (a drop of 132050.29 percentage points).
- Per Business Quant data, EDIT's Net Margin in the three quarters before Q3 2025 was -1487.84% (Q2 2025), -1633.49% (Q1 2025) and -148.33% (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 32.99% |
| 10 | Editas Medicine | 234.09 Mn | -477.66 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -332.98% |
| Jun 30, 2025 | -1,487.84% |
| Mar 31, 2025 | -1,633.49% |
| Dec 31, 2024 | -148.33% |
| Sep 30, 2024 | -101,870.49% |
| Jun 30, 2024 | -13,178.75% |
| Mar 31, 2024 | -5,458.15% |
| Dec 31, 2023 | -31.43% |
| Sep 30, 2023 | -843.68% |
| Jun 30, 2023 | -1,395.57% |
| Mar 31, 2023 | -497.78% |
| Dec 31, 2022 | -929.28% |
| Sep 30, 2022 | -132,680.95% |
| Jun 30, 2022 | -840.19% |
| Mar 31, 2022 | -746.05% |
| Dec 31, 2021 | -332.31% |
| Sep 30, 2021 | -630.66% |
| Jun 30, 2021 | -14,579.42% |
| Mar 31, 2021 | -872.87% |
| Dec 31, 2020 | -547.32% |
API Access
Editas Medicine Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=EDIT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "EDIT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=EDIT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();